360 related articles for article (PubMed ID: 23746277)
1. A focus on heme oxygenase-1 (HO-1) inhibitors.
Pittalà V; Salerno L; Romeo G; Modica MN; Siracusa MA
Curr Med Chem; 2013; 20(30):3711-32. PubMed ID: 23746277
[TBL] [Abstract][Full Text] [Related]
2. Immune Modulation by Inhibitors of the HO System.
Fernández-Fierro A; Funes SC; Rios M; Covián C; González J; Kalergis AM
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396647
[TBL] [Abstract][Full Text] [Related]
3. Structural Insights into Azole-based Inhibitors of Heme Oxygenase-1: Development of Selective Compounds for Therapeutic Applications.
Rahman MN; Vukomanovic D; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
Curr Med Chem; 2018; 25(42):5803-5821. PubMed ID: 30674243
[TBL] [Abstract][Full Text] [Related]
4. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.
Salerno L; Floresta G; Ciaffaglione V; Gentile D; Margani F; Turnaturi R; Rescifina A; Pittalà V
Eur J Med Chem; 2019 Apr; 167():439-453. PubMed ID: 30784878
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms.
Kinobe RT; Vlahakis JZ; Vreman HJ; Stevenson DK; Brien JF; Szarek WA; Nakatsu K
Br J Pharmacol; 2006 Feb; 147(3):307-15. PubMed ID: 16331285
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of the heme oxygenase - carbon monoxide system: on the doorstep of the clinic?
Kinobe RT; Dercho RA; Nakatsu K
Can J Physiol Pharmacol; 2008 Sep; 86(9):577-99. PubMed ID: 18758507
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of azalanstat analogues as heme oxygenase inhibitors.
Vlahakis JZ; Kinobe RT; Bowers RJ; Brien JF; Nakatsu K; Szarek WA
Bioorg Med Chem Lett; 2005 Mar; 15(5):1457-61. PubMed ID: 15713406
[TBL] [Abstract][Full Text] [Related]
8. X-ray crystallographic and biochemical characterization of the inhibitory action of an imidazole-dioxolane compound on heme oxygenase.
Sugishima M; Higashimoto Y; Oishi T; Takahashi H; Sakamoto H; Noguchi M; Fukuyama K
Biochemistry; 2007 Feb; 46(7):1860-7. PubMed ID: 17253780
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins.
Wong RJ; Vreman HJ; Schulz S; Kalish FS; Pierce NW; Stevenson DK
J Perinatol; 2011 Apr; 31 Suppl 1():S35-41. PubMed ID: 21448202
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of novel imidazole-dioxolane heme oxygenase inhibitors in renal proximal tubule epithelial cells.
Kinobe RT; Ji Y; Vlahakis JZ; Motterlini R; Brien JF; Szarek WA; Nakatsu K
J Pharmacol Exp Ther; 2007 Dec; 323(3):763-70. PubMed ID: 17761847
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds.
Rahman MN; Vukomanovic D; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
J R Soc Interface; 2013 Jan; 10(78):20120697. PubMed ID: 23097500
[TBL] [Abstract][Full Text] [Related]
12. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.
Salerno L; Pittalà V; Romeo G; Modica MN; Marrazzo A; Siracusa MA; Sorrenti V; Di Giacomo C; Vanella L; Parayath NN; Greish K
Eur J Med Chem; 2015; 96():162-72. PubMed ID: 25874340
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment.
Mucha O; Podkalicka P; Mikulski M; Barwacz S; Andrysiak K; Biela A; Mieczkowski M; Kachamakova-Trojanowska N; Ryszawy D; Białas A; Szelążek B; Grudnik P; Majewska E; Michalik K; Jakubiec K; Bień M; Witkowska N; Gluza K; Ekonomiuk D; Sitarz K; Gałęzowski M; Brzózka K; Dubin G; Józkowicz A; Dulak J; Łoboda A
Arch Biochem Biophys; 2019 Aug; 671():130-142. PubMed ID: 31276659
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
Bioorg Med Chem; 2013 Nov; 21(21):6788-95. PubMed ID: 24021581
[TBL] [Abstract][Full Text] [Related]
15. Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors.
Intagliata S; Salerno L; Ciaffaglione V; Leonardi C; Fallica AN; Carota G; Amata E; Marrazzo A; Pittalà V; Romeo G
Eur J Med Chem; 2019 Dec; 183():111703. PubMed ID: 31550661
[TBL] [Abstract][Full Text] [Related]
16. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors.
Vlahakis JZ; Kinobe RT; Bowers RJ; Brien JF; Nakatsu K; Szarek WA
J Med Chem; 2006 Jul; 49(14):4437-41. PubMed ID: 16821802
[TBL] [Abstract][Full Text] [Related]
17. A significant role for the heme oxygenase-1 gene in endothelial cell cycle progression.
Kushida T; Quan S; Yang L; Ikehara S; Kappas A; Abraham NG
Biochem Biophys Res Commun; 2002 Feb; 291(1):68-75. PubMed ID: 11829463
[TBL] [Abstract][Full Text] [Related]
18. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
Tongers J; Fiedler B; König D; Kempf T; Klein G; Heineke J; Kraft T; Gambaryan S; Lohmann SM; Drexler H; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):545-52. PubMed ID: 15276480
[TBL] [Abstract][Full Text] [Related]
19. The macrophage heme-heme oxygenase-1 system and its role in inflammation.
Vijayan V; Wagener FADTG; Immenschuh S
Biochem Pharmacol; 2018 Jul; 153():159-167. PubMed ID: 29452096
[TBL] [Abstract][Full Text] [Related]
20. Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia.
Salerno L; Romeo G; Modica MN; Amata E; Sorrenti V; Barbagallo I; Pittalà V
Eur J Med Chem; 2017 Dec; 142():163-178. PubMed ID: 28756878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
